{"schema_version":"secwatch.filing_event.v1","accession":"0000055529-22-000014","form_type":"8-K","ticker":"KEQU","cik":"0000055529","company_name":"KEWAUNEE SCIENTIFIC CORP /DE/","filed_at":"2022-09-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:57.887639+00:00","generated_at":"2026-06-23T13:15:06.388853+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Kewaunee Scientific Q1 FY2023 net loss narrows to $0.27/share; sales up 27% YoY","bullets":["Sales $50.1M, up 26.9% YoY from $39.5M; net loss of $747K vs $1.35M loss a year earlier.","Diluted EPS loss $0.27 vs loss $0.48; EBITDA improved to $275K from -$342K.","Order backlog $174M, a record for fourth time in five quarters, up from $120.6M a year ago.","Domestic segment swung to net income of $98K from loss; International net income rose to $687K.","Cash $21.5M; no short-term debt; long-term debt $29.5M; debt-to-equity 1.09-to-1."],"urls":{"canonical":"https://secwatch.observer/filing/0000055529-22-000014","json":"https://secwatch.observer/filing/0000055529-22-000014.json","markdown":"https://secwatch.observer/filing/0000055529-22-000014.md","text":"https://secwatch.observer/filing/0000055529-22-000014.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/55529/000005552922000014/0000055529-22-000014-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/55529/000005552922000014/kequ-20220908.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T13:15:06.388853+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}